Evidence map›Paper›PMID 20729199›Full record

ArticleThe Journal of biological chemistry2010

Calmodulin suppresses synaptotagmin-2 transcription in cortical neurons.

Zhiping P Pang, Wei Xu, Peng Cao, Thomas C Südhof

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Role of Calmodulin vs. Synaptotagmin in Exocytosis.Frontiers in molecular neuroscience · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Calmodulin regulates CaThe Journal of biological chemistry · 2017
    Article
  10. Synaptotagmin2 (Syt2) Drives Fast Release Redundantly with Syt1 at the Output Synapses of Parvalbumin-Expressing Inhibitory Neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  11. Calmodulin regulates KCNQ2 function in epilepsy.American journal of translational research · 2016
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Membrane-tethered monomeric neurexin LNS-domain triggers synapse formation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
  17. Complexin activates exocytosis of distinct secretory vesicles controlled by different synaptotagmins.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
  18. C-terminal complexin sequence is selectively required for clamping and priming but not for Ca2+ triggering of synaptic exocytosis.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
  19. Article
  20. Decrease in calcium concentration triggers neuronal retinoic acid synthesis during homeostatic synaptic plasticity.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Zhiping P PangDepartment of Molecular and Cellular Physiology, Stanford University, Palo Alto, California 94304-5543, USA.
Wei Xu
Peng Cao
Thomas C Südhof
Cellular Research (United States) · USHoward Hughes Medical Institute · USStanford University · US

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

Calmodulin (CaM) is a ubiquitous Ca(2+) sensor protein that plays a pivotal role in regulating innumerable neuronal functions, including synaptic transmission. In cortical neurons, most neurotransmitter release is triggered by Ca(2+) binding to synaptotagmin-1; however, a second delayed phase of release, referred to as asynchronous release, is triggered by Ca(2+) binding to an unidentified secondary Ca(2+) sensor. To test whether CaM could be the enigmatic Ca(2+) sensor for asynchronous release, we now use in cultured neurons short hairpin RNAs that suppress expression of ∼70% of all neuronal CaM isoforms. Surprisingly, we found that in synaptotagmin-1 knock-out neurons, the CaM knockdown caused a paradoxical rescue of synchronous release, instead of a block of asynchronous release. Gene and protein expression studies revealed that both in wild-type and in synaptotagmin-1 knock-out neurons, the CaM knockdown altered expression of >200 genes, including that encoding synaptotagmin-2. Synaptotagmin-2 expression was increased several-fold by the CaM knockdown, which accounted for the paradoxical rescue of synchronous release in synaptotagmin-1 knock-out neurons by the CaM knockdown. Interestingly, the CaM knockdown primarily activated genes that are preferentially expressed in caudal brain regions, whereas it repressed genes in rostral brain regions. Consistent with this correlation, quantifications of protein levels in adult mice uncovered an inverse relationship of CaM and synaptotagmin-2 levels in mouse forebrain, brain stem, and spinal cord. Finally, we employed molecular replacement experiments using a knockdown rescue approach to show that Ca(2+) binding to the C-lobe but not the N-lobe of CaM is required for suppression of synaptotagmin-2 expression in cortical neurons. Our data describe a previously unknown, Ca(2+)/CaM-dependent regulatory pathway that controls the expression of synaptic proteins in the rostral-caudal neuraxis.

Indexed as

Transcription, GeneticAnimalsBrainCalciumCalmodulinElectrophysiologyHumansLentivirusMiceMice, KnockoutModels, BiologicalNeuronsProtein IsoformsSynaptotagmin ISynaptotagmin IICalciumCalmodulinProtein IsoformsSynaptotagmin ISynaptotagmin II

Identifiers

PMID20729199
PMCPMC2962493
OpenAlexW2086481622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.